F X Kleber

Summary

Affiliation: Unfallkrankenhaus Berlin
Country: Germany

Publications

  1. ncbi Impairment of ventilatory efficiency in heart failure: prognostic impact
    F X Kleber
    Medizinische Klinik und Poliklinik I, Universitatsklinikum Charite, Arbeitsgruppe Medizinische Biometrie, Humboldt Universitat zu Berlin, Berlin, Germany
    Circulation 101:2803-9. 2000
  2. ncbi Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
    Franz Xaver Kleber
    Department Internal Medicine, Unfallkrankenhaus, Lehrkrankenhaus der Freien Universität Berlin, Berlin, Germany
    Am Heart J 145:614-21. 2003
  3. ncbi [Structure of the Australian system of 'Diagnosis Related Groups' regarding cardiovascular diseases and corresponding cost weights in Germany]
    D Wietholt
    Klinik für Innere Medizin Kardiologie, Unfallkrankenhaus Berlin e V, Warener Strasse 7, 12683 Berlin, Germany
    Z Kardiol 92:619-26. 2003
  4. ncbi Socioeconomic aspects of ACE inhibition in the secondary prevention in cardiovascular diseases
    F X Kleber
    , , Berlin, Germany
    Am J Hypertens 7:112S-116S. 1994
  5. ncbi Passive containment and reverse remodeling by a novel textile cardiac support device
    W F Konertz
    Department of Cardiovascular Surgery, Charite, Berlin, Germany
    Circulation 104:I270-5. 2001

Detail Information

Publications6

  1. ncbi Impairment of ventilatory efficiency in heart failure: prognostic impact
    F X Kleber
    Medizinische Klinik und Poliklinik I, Universitatsklinikum Charite, Arbeitsgruppe Medizinische Biometrie, Humboldt Universitat zu Berlin, Berlin, Germany
    Circulation 101:2803-9. 2000
    ..Impairment of ventilatory efficiency in congestive heart failure (CHF) correlates well with symptomatology and contributes importantly to dyspnea...
  2. ncbi Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
    Franz Xaver Kleber
    Department Internal Medicine, Unfallkrankenhaus, Lehrkrankenhaus der Freien Universität Berlin, Berlin, Germany
    Am Heart J 145:614-21. 2003
    ..We compared the efficacy and safety of the low-molecular weight heparin enoxaparin with unfractionated heparin (UFH) for the prevention of venous thromboembolic disease in patients with heart failure or severe respiratory disease...
  3. ncbi [Structure of the Australian system of 'Diagnosis Related Groups' regarding cardiovascular diseases and corresponding cost weights in Germany]
    D Wietholt
    Klinik für Innere Medizin Kardiologie, Unfallkrankenhaus Berlin e V, Warener Strasse 7, 12683 Berlin, Germany
    Z Kardiol 92:619-26. 2003
    ..This article focuses on the structure of the Australian DRG system (AR-DRG 4.1) regarding the diseases of the cardiovascular system and corresponding cost weights in Germany (G-DRG 1.0)...
  4. ncbi Socioeconomic aspects of ACE inhibition in the secondary prevention in cardiovascular diseases
    F X Kleber
    , , Berlin, Germany
    Am J Hypertens 7:112S-116S. 1994
    ..Thus in many cardiovascular diseases angiotensin-converting enzyme inhibitors have a favorable cost-benefit ratio and can be recommended for broader use...
  5. ncbi Passive containment and reverse remodeling by a novel textile cardiac support device
    W F Konertz
    Department of Cardiovascular Surgery, Charite, Berlin, Germany
    Circulation 104:I270-5. 2001
    ..We hypothesize that such a device could provide benefit for stable heart failure patients in New York Heart Association (NYHA) class II and III...